Related Experiment Videos
Anaerobic infection therapy
1Department of Internal Medicine and Infectious Diseases, Athens University Medical School, Athens, Greece. hgiama@ath.forthnet.gr
Abstract:
Anaerobes are involved mainly in abdominal surgical infections and the Bacteroides fragilis group is still predominant in such infections. By definition surgery itself plays the major role in therapy while antibiotics have an adjunctive role. Depending on the source of the infection, several combinations of either an older cephalosporin for community acquired infections or a more advanced cephalosporin, an aminoglycoside, aztreonam or a quinolone with metronidazole or clindamycin for nosocomial infections, are acceptable therapeutic regimens. Cefoxitin, cefotetan, carbapenems and the inhibitors may also be used as monotherapy. However whenever selecting an antibiotic to combat anaerobes the following points should be seriously considered. The value of anaerobic cultures which should always be obtained in order to be used for local resistance surveillance. There is a lack of important newer antimicrobials active against anaerobes. Studies of newer antibiotics generally exclude critically ill patients and are chiefly made up of appendicitis cases which by definition end up with >90% cure rate. The importance of hyperbaric oxygen in selected cases should be considered.
Insights
Antibiotic selection for anaerobic infections, particularly abdominal surgical infections, requires careful consideration of local resistance patterns and available antimicrobial agents. Newer antibiotics often lack robust data in critically ill patients, highlighting the need for strategic treatment approaches.
Area of Science:
- Microbiology
- Infectious Diseases
- Surgical Infections
Background:
- Anaerobic bacteria, especially the Bacteroides fragilis group, are primary pathogens in abdominal surgical infections.
- Surgical intervention is the cornerstone of therapy, with antibiotics serving an adjunctive role in managing these infections.
Purpose of the Study:
- To review current therapeutic regimens for anaerobic infections, focusing on antibiotic selection.
- To highlight critical considerations for antimicrobial therapy against anaerobes in surgical settings.
Main Methods:
- Review of established and emerging antibiotic strategies for anaerobic infections.
- Discussion of factors influencing antibiotic choice, including infection source and patient population.
- Emphasis on the importance of anaerobic cultures for resistance surveillance.
Main Results:
- Various antibiotic combinations (cephalosporins, aminoglycosides, aztreonam, quinolones with metronidazole or clindamycin) are effective.
- Monotherapy options include cefoxitin, cefotetan, carbapenems, and beta-lactamase inhibitors.
- Limited development of novel antimicrobials active against anaerobes and data gaps in critically ill patients.
Conclusions:
- Antibiotic selection must account for infection source, local resistance data, and patient status.
- Hyperbaric oxygen may be a valuable adjunct in specific anaerobic infection cases.
- Continued surveillance and research into effective anaerobic antimicrobial therapies are warranted.